![Journal cover image](https://secure.syndetics.com/index.aspx?isbn=/lc.gif&issn=1538-3598&client=dukeuniv)
Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI.
Publication
, Journal Article
Lopes, RD; de Barros E Silva, PGM; Damiani, LP; Santos, RHN; Alexander, JH; Granger, CB; Berwanger, O
Published in: JAMA
February 25, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
February 25, 2020
Volume
323
Issue
8
Start / End Page
787 / 789
Location
United States
Related Subject Headings
- Percutaneous Coronary Intervention
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- General & Internal Medicine
- Cardiovascular Diseases
- Atorvastatin
- Acute Coronary Syndrome
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lopes, R. D., de Barros E Silva, P. G. M., Damiani, L. P., Santos, R. H. N., Alexander, J. H., Granger, C. B., & Berwanger, O. (2020). Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI. JAMA, 323(8), 787–789. https://doi.org/10.1001/jama.2020.0118
Lopes, Renato D., Pedro G. M. de Barros E Silva, Lucas Petri Damiani, Renato Hideo Nakagawa Santos, John H. Alexander, Christopher B. Granger, and Otavio Berwanger. “Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI.” JAMA 323, no. 8 (February 25, 2020): 787–89. https://doi.org/10.1001/jama.2020.0118.
Lopes RD, de Barros E Silva PGM, Damiani LP, Santos RHN, Alexander JH, Granger CB, et al. Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI. JAMA. 2020 Feb 25;323(8):787–9.
Lopes, Renato D., et al. “Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI.” JAMA, vol. 323, no. 8, Feb. 2020, pp. 787–89. Pubmed, doi:10.1001/jama.2020.0118.
Lopes RD, de Barros E Silva PGM, Damiani LP, Santos RHN, Alexander JH, Granger CB, Berwanger O. Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI. JAMA. 2020 Feb 25;323(8):787–789.
![Journal cover image](https://secure.syndetics.com/index.aspx?isbn=/lc.gif&issn=1538-3598&client=dukeuniv)
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
February 25, 2020
Volume
323
Issue
8
Start / End Page
787 / 789
Location
United States
Related Subject Headings
- Percutaneous Coronary Intervention
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- General & Internal Medicine
- Cardiovascular Diseases
- Atorvastatin
- Acute Coronary Syndrome
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences